Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.75 |
| ▸ | HPGD | P15428 | 4/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.75 |
| ▸ | MEN1 | O00255 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | CLK2 | P49760 | 1/20 | 0.53 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TOP2A | P11388 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28653434 | 0.90 | KDM4E (0.71) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL10061991 | 0.89 | KDM4E (0.64) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL17211589 | 0.87 | KDM4E (0.86) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| Moxifloxacin SCHEMBL24007 | 0.87 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| Moxifloxacin SCHEMBL12015472 | 0.87 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL14010189 | 0.87 | KDM4E (0.86) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| Moxifloxacin SCHEMBL4774670 | 0.87 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL22273495 | 0.87 | KDM4E (0.75) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| Moxifloxacin SCHEMBL21783209 | 0.87 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| Moxifloxacin SCHEMBL12156451 | 0.87 | KDM4E (0.98) | KDM4EALDH1A1HPGDHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877945-B2 | Redox drug derivatives | REDX PHARMA LIMITED (GB) | 2014-11-04 | — | — | US | disclosed |
| US-20120077974-A1 | REDOX DRUG DERIVATIVES | REDX PHARMA PLC (GB) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077974-A1 | REDOX DRUG DERIVATIVES | NOX4, AOX1, ALDH5A1 | KDM4E 1523/4885ALDH1A1 5/4885HPGD 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.